Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS.
Iris Kuss, David Morris, Neil Fleshner, Jeanny B Aragon-Ching, Joan Carles, Susan Feyerabend, Matthew R Smith, Teuvo L J Tammela, Christian Gratzke, Hakim Mahammedi, Marie-Aude Le Berre, Christopher Pieczonka, Neal D Shore, Egils Vjaters, Toni Sarapohja, Frank Verholen, Urban Emmenegger, Martin Richardet, Antti Rannikko, Karim Fizazi, Patrick Werbrouck, Raoul S Concepcion, Markus Grabbert, Vilnis Lietuvietis, Felipe M Cruz, Adriano Paula, Glauco Silveira
The oncologist 2024;29(7):581-588